Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.8 USD | +0.73% | -1.21% | -1.98% |
01:29pm | Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126 | MT |
Apr. 22 | Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.98% | 186B | |
-1.46% | 107B | |
-3.42% | 67.57B | |
+8.61% | 50.7B | |
+15.68% | 47.2B | |
-0.45% | 39.72B | |
+11.17% | 27.48B | |
+2.58% | 25.65B | |
+13.37% | 24.97B | |
-0.16% | 24.82B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Abbott Laboratories : Gets FDA Clearance for Portico with FlexNav Transcatheter Aortic Valve Replacement